冠状动脉损伤复杂性和冠状动脉微血管功能障碍在NSTEMI患者预后中的相互作用
Ping Lin1,2,3,4, Yuxuan Zhang1,2,3,4, Zining Chen1,2,3,4
1Department of Cardiology, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, 310009, China.
概括
美国心脏病学会/美国心脏协会 (ACC/AHA) 病变分类预测NSTEMI患者的主要不良心血管事件 (MACE). 冠状动脉微血管疾病 (CMD) 与复杂的病变有关,并调解其预后影响.
科学领域:
- 心脏病学 心脏病学
- 干预心脏病学 干预心脏病学
- 血管生物学 血管生物学
背景情况:
- 在NSTEMI患者中ACC/AHA病变分类的预后意义需要进一步调查,特别是关于其与冠状动脉微血管疾病 (CMD) 的相互作用.
- 了解这种关系对于完善NSTEMI中的风险分层和治疗策略至关重要.
研究的目的:
- 评估在NSTEMI患者中ACC/AHA病变分类的预后价值.
- 评估损伤复杂性和CMD之间的相互作用,以预测心血管事件.
主要方法:
- 分析了2212名NSTEMI患者的队列.
- 使用修改的ACC/AHA分类来评估损伤复杂性.
- 测量了皮肤穿透后冠状动脉干预 (PCI) 侵入性微血管抵抗 (IMR).
- 主要终点是2年随访期间发生的重大心血管不良事件 (MACE).
主要成果:
- 患有复杂病变的患者与患有简单病变的患者相比,在2年内MACE的发生率显著更高 (13.5%对7.5%,P < 0.001).
- 损伤复杂性独立预测了MACE (HR 1.48,P = 0.011),其添加改善了风险预测模型.
- 冠状动脉微血管疾病 (CMD) 与复杂的病变密切相关 (OR 1.74,P = 0.002).
- 调解分析显示,CMD占病变复杂性对MACE影响的17% (P = 0.002).
结论:
- ACC/AHA病变分类是NSTEMI患者风险分层的一个有价值的工具,特别是那些没有CMD的患者.
- 冠状动脉疾病与复杂的冠状动脉病变独立相关.
- CMD部分介导复杂病变对MACE的不良预后影响,突出其在NSTEMI结果中的作用.
相关概念视频
01:30Acute Coronary Syndrome I: Introduction
744
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
744
01:19Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
329
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
329
01:30Acute Coronary Syndrome III: Diagnostic Studies
200
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
200
01:26Coronary Artery Disease II: Pathophysiology
348
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
348
01:28Acute Coronary Syndrome IV: Interprofessional Care
203
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
203
01:30Coronary Artery Disease III: Clinical Manifestations
311
Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
311